Applied Photophysics celebrates 50 years Kumar Jeetendra | April 22, 2021 Leatherhead, UK – 22nd April 2021 – Life Science Newswire – Applied Photophysics (AP) started in Mayfair, London, in April 1971. An unusual place perhaps for a start-up scientific instrument company, was although explained by the fact that the origins of the company lie within the Royal Institution (RI). The Royal Institution has been at …
FBL pioneers the development of its patented enzymatic route of synthesis for Molunpiravir an investigational ‘orally active’ therapeutic alternative for COVID 19 Kumar Jeetendra | April 16, 2021 “With the more we understand of COVID 19 the less we fear it and it is through this understanding that we can potentially create impressive therapeutic developments” says Mr. Prashant Nagre, CEO, FBL as he expounds further on the experimental antiviral drug Molnupiravir. Developed at Emory University in Atlanta by Drug Innovation Ventures at Emory …
Malvern Panalytical and Concept Life Sciences announce integration Kumar Jeetendra | April 14, 2021 Malvern Panalytical (Malvern, UK and Almelo, The Netherlands), manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The integration will expand the existing analytical instrument and service relationship (Amplify Analytics) to include the Chemistry and Biology services of CLS. Both entities are operating …
AnteoTech Secures CE Certification for Its Versatile EuGeni™ Rapid Diagnostic Platform Kumar Jeetendra | April 13, 2021 Brisbane, AUS, April 13, 2021 – AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution. The digital multi-test EuGeni Reader eliminates the human error associated with current lateral flow test interpretation, and can support …
Hester acquires technology from ICAR – IVRI for the production and commercialization of Classical Swine Fever Vaccine & Sheep Pox Vaccine Kumar Jeetendra | April 8, 2021 8 April 2021: Hester has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute),for acquiring technologies for the production and commercialisation of the following vaccines: 1. Classical Swine Fever Vaccine 2. Sheep Pox Vaccine These vaccines are the first that have been developed within the country by using locally …
Dr Rajesh Shah has been appointed Country General Manager of Azbil Telstar’s subsidiary in India Kumar Jeetendra | April 6, 2021 Terrassa (Barcelona) 2021, March 29th. Azbil Telstar announces the appointment of Dr Rajesh Shah as the Country General Manager of the subsidiary of the company in Hyderabad, India. Rajesh is going to focus his responsibility on the development of an extensive plan to address an ongoing growth demand in the region for Life Sciences service …
SignalChem Enters a Clinical Trial Collaboration with Merck to Evaluate the Effect of SLC-391 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer Kumar Jeetendra | March 27, 2021 VANCOUVER, BRITISH COLUMBIA – March 25, 2021 – Life Science Newswire – SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, announces a collaboration with Merck, known as MSD outside of the United States and Canada, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with …
Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution Kumar Jeetendra | March 23, 2021 TORONTO, Canada – (March 23, 2021) – Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation software, have announced a strategic technology collaboration to develop an integrated and comprehensive software automation platform for Thermo Fisher’s standardized COVID-19 Testing Platform. The integration will result in increased testing throughput and support …
Presenting Inhalytix™: Solution for analysing and managing inhaler test data from Copley Kumar Jeetendra | March 22, 2021 Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a standardized approach to cascade impactor data analysis, efficiently converting raw data into performance-defining metrics for all inhaled products. Cascade impactors determine aerodynamic particle size distribution (APSD), a critical quality attribute for inhaled drug delivery. Inhalytix™ is …
Roche and GenMark Diagnostics signs Definitive Merger Agreement Kumar Jeetendra | March 20, 2021 Roche, Basel, Switzerland, and GenMark Diagnostics, Carlsbad, Calif, have entered into a definitive merger agreement for Roche to completely acquire GenMark at a price of $24.05 per share in an all-cash trade. This corresponds to a total transaction value of approximately $1.8 billion on a fully diluted basis. The merger agreement has been unanimously approved …
CN Bio presents the PhysioMimix™ OOC Multi-Organ Microphysiological System Kumar Jeetendra | March 17, 2021 CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS. The next-generation system unites CN Bio’s in vitro 3D liver model, whose phenotype and functions mimic that in vivo, with a range of other organs to …
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC Kumar Jeetendra | March 17, 2021 PerkinElmer, Inc. has announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). “Oxford Immunotec’s global role in fighting tuberculosis, particularly its trademark product, the T-SPOT®.TB test, and the operations it has built are remarkable,” said Prahlad Singh, PerkinElmer president and chief executive officer. “We recognize the distinct …
